Filter
415
Text search:
council
of
pharmacists
Featured
Recommendations
20
New Publications
121
Language
Document type
No document type
211
Studies & Reports
88
Guidelines
63
Strategic & Response Plan
17
Manuals
16
Training Material
9
Situation Updates
5
Fact sheets
4
Resource Platforms
2
Countries / Regions
South Africa
29
India
26
Nigeria
20
Kenya
20
Namibia
14
Uganda
13
Zambia
13
Tanzania
13
Rwanda
13
Ghana
12
Nepal
12
Ethiopia
11
Sierra Leone
9
Liberia
9
Global
8
Zimbabwe
7
Myanmar / Burma
7
Western and Central Europe
7
Africa
7
Syria
6
Bangladesh
6
Malawi
5
Ukraine
5
Philippines
4
Indonesia
4
Botswana
4
South–East Asia Region
4
Guinea
3
Burkina Faso
3
Sudan
3
Lesotho
3
Saudi Arabia
2
Pakistan
2
Iraq
2
Jordan
2
Lebanon
2
Mozambique
2
Eswatini/ Swaziland
2
Eastern Europe and Central Asia
2
Fiji
2
Eastern Europe
2
United Kingdom
2
Guinea-Bissau
1
Morocco
1
Haiti
1
Afghanistan
1
Germany
1
Turkey
1
Cambodia
1
Thailand
1
Hungary
1
Greece
1
Angola
1
Sri Lanka
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Latin America and the Carribbean
1
Bhutan
1
Venezuela
1
Poland
1
Albania
1
Russia
1
Bulgaria
1
Romania
1
Moldova
1
Slovakia
1
Iran
1
Australia
1
Georgia
1
Maldives
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
240
Public Health
17
Clinical Guidelines
17
Women & Child Health
13
Key Resources
8
Capacity Building
7
Pharmacy & Technologies
5
Toolboxes
AMR
51
Pharmacy
51
Caregiver
15
TB
13
HIV
11
Mental Health
10
COVID-19
10
NCDs
10
Conflict
8
Rapid Response
3
Planetary Health
3
NTDs
3
Disability
2
Ebola & Marburg
2
Zika
2
Malaria
2
Polio
1
Specific Hazards
1
Global Health Education
1
Social Ethics
1
2.0 Rapid Response
1
July 2014
This report was made possible through support provided by the One Million Community Health Workers Campaign, mPowering Frontline Health Workers, Intel, and USAID. This report was authored by Cindil Redick for mPowering Frontline Health Workers under the terms
...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these c
...
Waste Management & Research 39(1) DOI: 10.1177/0734242X211029175
What We Know, What We Don’t Know, and What We Need to Do
More than 700 000 people lose their life to suicide every year. A core foundation of suicide prevention is the timely registration and regular monitoring of suicide and self-harm. Surveillance data
...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neuro
...
Hypertension is referred to as a “silent killer”. Most people with hypertension are unaware of their condition as in most cases, they experience no warning signs or symptoms hence they are not identified or treated. Hypertention is associated wi
...
SIGN 143. A national clinical guideline
Published May 2015, Revised 2018
This report - the largest of its kind to date - draws on the experiences of over 8,500 women and 300 health professionals across eight countries. It exposes the aggressive marketing practices used b
...
These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource
...
A systematic analysis for the Global Burden of Disease Study 2019. The Lancet Vol.399 Issue 10341 p.2129-2154
Human resources for health (HRH) include a range of occupations that aim to promote or
...
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
One important application of digital health in TB patient care is the support that it can lend to medication adherence. TB programmes have already been using short message service (SMS), video-supported treatment (VOT)
...
These guidelines have been developed in simple, user-friendly language and they explain the procedures for patients’ access to and the safe management of Schedule I and II drugs that are necessary for the treatment and relief
...
